There are a couple of things to watch. If we see more of these events it means that other banks are exposed to a similar situation and have learned from last week’s events that making margin calls early is the best way to limit damage
According to U.S. Trade Representative Katherine Tai, the U.S. isn’t ready to lift tariffs on Chinese imports in the near future but might be open to trade negotiations with Beijing. President Joe Biden is expected to unveil his infrastructure-led stimulus program.
Is the tech selloff finally over? Bulls are eagerly waiting for that question to be answered after watching the painful effect rising bond yields have had
Mergers are incredibly easy to get wrong and challenging to get right. Sidestepping culture is the number one mistake leaders make during mergers and acquisitions, particularly in a global context.
Announcements of companies going public via SPAC seem to have been hitting the news with such frequency that it is rare for one to get major attention. That can’t be said of the news that WeWork is partnering with the Bow Capital SPAC BowX (BOWX)
When we think about automation, it is usually manufacturing, factory floor improvements, and companies like Rockwell Automation (ROK) that come to mind, but we are seeing an acceleration in the adoption of automation occurring in the white-collar and professional services world.
Helping boost futures are bank stocks, trading higher on the news they can resume buyback activity and boost dividends beginning at the end of June. Meanwhile, investors will continue to monitor the fallout from the Suez Canal blockage.
Many consider the U.S. SIP to be the example for market data around the world. However, closer to home, it is at the center of a lot of the "data debate."
By using data science and artificial intelligence, Anita is helping build a smarter electronic trading platform across the global equity business, as well as fixed income, currencies and commodities (FICC).
Available to investors through the Defiance Nasdaq Junior Biotechnology ETF (IBBJ), this strategy offers a "pure-play" approach to investing in some of today's most important healthcare R&D companies.
There are some signs that we could be headed for a pretty big dip right now, and I am looking in a seemingly unlikely place for confirmation or refutation of that view